Hims & Hers Health (HIMS) Exchange Rate Effect (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Exchange Rate Effect came in at -$2.4 million in Q1 2026, down 1079.42% year-on-year from $243000.0 in Q1 2025, and down 187.37% quarter-over-quarter from $2.7 million in Q4 2025.
Hims & Hers Health (HIMS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Exchange Rate Effect across 7 years of filings, most recently posting -$2.4 million for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$2.4 million, down 1079.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$115000.0 (down 296.55% YoY), and the FY2025 annual result was $2.5 million, up 1028.89% from the prior year.
- Exchange Rate Effect came in at -$2.4 million for Q1 2026 at Hims & Hers Health, down from $2.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.7 million in Q4 2025 to a low of -$2.4 million in Q1 2026.
- The 5-year median for Exchange Rate Effect is $2000.0 (2024), against an average of -$12117.6.
- Across the five-year window, Exchange Rate Effect plunged 1250.0% in 2022 and jumped 102800.0% in 2025, its largest moves.
- Hims & Hers Health's Exchange Rate Effect stood at -$17000.0 in 2022, then tumbled by 182.35% to -$48000.0 in 2023, then plunged by 860.42% to -$461000.0 in 2024, then soared by 690.89% to $2.7 million in 2025, then tumbled by 187.37% to -$2.4 million in 2026.
- The last three Exchange Rate Effect figures came in at -$2.4 million (Q1 2026), $2.7 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 243,000.00 |
| Mar 31, 2025 | 243,000.00 |
| Dec 31, 2024 | -461,000.00 |
| Dec 31, 2024 | -461,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -48,000.00 |
| Dec 31, 2023 | -48,000.00 |